These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15940882)

  • 1. Fishing for a cure. Does the tiny zebrafish hold a key to stopping tumor growth?
    Kiser K
    Minn Med; 2005 Apr; 88(4):8-9. PubMed ID: 15940882
    [No Abstract]   [Full Text] [Related]  

  • 2. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle.
    Bocci G; Loupakis F
    Pharmacogenomics; 2011 Aug; 12(8):1077-80. PubMed ID: 21843059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenic agents in breast cancer.
    Salter JT; Miller KD
    Cancer Invest; 2007 Oct; 25(7):518-26. PubMed ID: 18027149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Are antiangiogenic antibodies universal for solid tumor?].
    Ray-Coquard I; Bachelot T; Saba C; Confavreux C; Brantus JF; Rustam F; Ghesquière H; Sebban C; Biron P; Guastalla JP; Blay JY
    Bull Cancer; 2007 Jul; 94 Spec No():S191-6. PubMed ID: 17846004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?].
    Grépin R; Pagès G
    J Soc Biol; 2009; 203(2):181-92. PubMed ID: 19527632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
    Jayson G; Armand JP; Berdel WE
    Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast tumour angiogenesis.
    Fox SB; Generali DG; Harris AL
    Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Therapies in Cancer - Fourth International Congress. Angiogenesis inhibition.
    Tawbi H; Agarwala SS
    IDrugs; 2005 Dec; 8(12):984-6. PubMed ID: 16320129
    [No Abstract]   [Full Text] [Related]  

  • 13. A new weapon for attacking tumor blood vessels.
    Semenza GL
    N Engl J Med; 2008 May; 358(19):2066-7. PubMed ID: 18463385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumour angiogenesis inhibition by therapeutic monoclonal antibodies].
    Cézé N; Lecomte T; Watier H
    Med Sci (Paris); 2009 Dec; 25(12):1099-104. PubMed ID: 20035685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New medications; bevacizumab].
    Cohen AF; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in the modulation of tumor angiogenesis.
    Presta M; Ribatti D
    Eur Cytokine Netw; 2009 Dec; 20(4):157. PubMed ID: 20167553
    [No Abstract]   [Full Text] [Related]  

  • 17. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis as a strategic target for ovarian cancer therapy.
    Spannuth WA; Sood AK; Coleman RL
    Nat Clin Pract Oncol; 2008 Apr; 5(4):194-204. PubMed ID: 18268546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
    Cao Y; Liu Q
    Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.